Daniel M. Klein - 01 Mar 2023 Form 4 Insider Report for Physicians Realty Trust

Role: SVP - Deputy CIO
Signature: Christopher M. Bartoli, as attorney-in-fact
Issuer symbol: N/A
Transactions as of: 01 Mar 2023
Net transactions value: -$82,511
Form type: 4
Filing time: 03 Mar 2023, 15:49:53 UTC
Previous filing: 27 Feb 2023
Next filing: 22 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DOC	Common shares, $0.01 par value	Award	$0	+14,735	+13%	$0.000000	130,604	01 Mar 2023	Direct	F1
transaction	DOC	Common shares, $0.01 par value	Tax liability	$82,511	-5,613	-4.3%	$14.70	124,991	01 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DOC	2023 Performance Based Restricted Share Unit Grant	Award	$0	+22,103		$0.000000	22,103	01 Mar 2023	Common shares, $0.01 par value	22,103		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted common shares granted under the Issuer's 2013 Equity Incentive Plan (the "Plan"), which will vest on March 1, 2024, subject to the terms of the grant.
F2	March 1, 2023 grant of performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. The exact number of shares to be issued upon vesting depends upon, among other things, the Issuer's financial performance. Subject to continued service, the shares, if any, will be issued following the performance period end date of December 31, 2025.

Content

Represents restricted common shares granted under the Issuer's 2013 Equity Incentive Plan (the "Plan"), which will vest on March 1, 2024, subject to the terms of the grant.

March 1, 2023 grant of performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. The exact number of shares to be issued upon vesting depends upon, among other things, the Issuer's financial performance. Subject to continued service, the shares, if any, will be issued following the performance period end date of December 31, 2025.